SK82399A3 - Heteroaryl sulfonamide compounds, process for their preparation, pharmaceutical compositions containing them and their use - Google Patents

Heteroaryl sulfonamide compounds, process for their preparation, pharmaceutical compositions containing them and their use Download PDF

Info

Publication number
SK82399A3
SK82399A3 SK823-99A SK82399A SK82399A3 SK 82399 A3 SK82399 A3 SK 82399A3 SK 82399 A SK82399 A SK 82399A SK 82399 A3 SK82399 A3 SK 82399A3
Authority
SK
Slovakia
Prior art keywords
benzodioxan
ylmethyl
methyl
chloro
piperidyl
Prior art date
Application number
SK823-99A
Other languages
English (en)
Slovak (sk)
Inventor
Alan Martin Birch
Neil Wishart
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of SK82399A3 publication Critical patent/SK82399A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Light Receiving Elements (AREA)
  • Hydrogenated Pyridines (AREA)
SK823-99A 1996-12-27 1997-12-15 Heteroaryl sulfonamide compounds, process for their preparation, pharmaceutical compositions containing them and their use SK82399A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9627006.1A GB9627006D0 (en) 1996-12-27 1996-12-27 Therapeutic agents
PCT/EP1997/007034 WO1998029411A1 (en) 1996-12-27 1997-12-15 Sulfonamide compounds having 5-ht receptor activity

Publications (1)

Publication Number Publication Date
SK82399A3 true SK82399A3 (en) 2000-05-16

Family

ID=10805084

Family Applications (1)

Application Number Title Priority Date Filing Date
SK823-99A SK82399A3 (en) 1996-12-27 1997-12-15 Heteroaryl sulfonamide compounds, process for their preparation, pharmaceutical compositions containing them and their use

Country Status (19)

Country Link
US (1) US6136825A (ja)
EP (1) EP0948498A1 (ja)
JP (1) JP2001508419A (ja)
KR (1) KR20000062356A (ja)
CN (1) CN1247537A (ja)
AU (1) AU747545B2 (ja)
BG (1) BG103557A (ja)
BR (1) BR9714237A (ja)
CA (1) CA2275668A1 (ja)
GB (1) GB9627006D0 (ja)
HU (1) HUP0000489A3 (ja)
IL (1) IL130361A0 (ja)
NO (1) NO993172L (ja)
NZ (1) NZ336328A (ja)
PL (1) PL334254A1 (ja)
SK (1) SK82399A3 (ja)
TR (1) TR199901478T2 (ja)
WO (1) WO1998029411A1 (ja)
ZA (1) ZA9711551B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001514663A (ja) 1997-03-12 2001-09-11 エスモンド,ロバート ダブリュー. アルツハイマー病を処置または予防するための方法
GB9915617D0 (en) * 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
SE0002739D0 (sv) * 2000-07-21 2000-07-21 Pharmacia & Upjohn Ab New use
US6399617B1 (en) 2000-07-21 2002-06-04 Biovitrum Ab Use
WO2005080394A1 (en) * 2004-02-24 2005-09-01 Bioaxone Therapeutique Inc. 4-substituted piperidine derivatives
US20080299674A1 (en) * 2004-07-14 2008-12-04 Yoshikazu Kitano Novel Isonitrile Compound, Its Method Of Manufacture, A Marine Fouling Organism Larva Fluorescent, And A Method Of Detecting This Marine Fouling Organism Larva Using Said Marker
PT1831159E (pt) * 2004-12-21 2010-03-03 Hoffmann La Roche Derivados de tetralina e de indano e as suas utilizações
PL395470A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Sulfonamidowe pochodne amin alicyklicznych do leczenia chorób osrodkowego ukladu nerwowego

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
US5300523A (en) * 1988-07-28 1994-04-05 Bayer Aktiengesellschaft Substituted aminomethyltetralins and their heterocyclic analogues
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
FR2701479B1 (fr) * 1993-02-11 1995-05-12 Pf Medicament Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
GB9627006D0 (en) 1997-02-12
IL130361A0 (en) 2000-06-01
ZA9711551B (en) 1999-06-23
HUP0000489A2 (hu) 2000-12-28
US6136825A (en) 2000-10-24
HUP0000489A3 (en) 2001-06-28
NZ336328A (en) 2000-09-29
AU5758098A (en) 1998-07-31
CN1247537A (zh) 2000-03-15
WO1998029411A1 (en) 1998-07-09
PL334254A1 (en) 2000-02-14
CA2275668A1 (en) 1998-07-09
NO993172D0 (no) 1999-06-25
NO993172L (no) 1999-06-25
JP2001508419A (ja) 2001-06-26
BR9714237A (pt) 2000-04-18
BG103557A (en) 2000-06-30
TR199901478T2 (xx) 1999-09-21
EP0948498A1 (en) 1999-10-13
KR20000062356A (ko) 2000-10-25
AU747545B2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
US6353002B2 (en) Therapeutic agents
DE69619704T2 (de) Heteroacylcarbonsäureamiderivate
HRP960349A2 (en) Therapeutic agents
PL194118B1 (pl) Związki N-arylopiperydyny, sposób wytwarzania związków N-arylopiperydyny, oraz kompozycje farmaceutyczne zawierające te związki
US6218405B1 (en) Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
US6391891B1 (en) Bicyclic compounds as ligands for 5-HT1 receptors
SK2498A3 (en) Heterocyclylcarboxamide derivatives and their use as therapeutic agents
HU208817B (en) Process for producing thiazine- /or oxazine derivatives condensed with carbocyclic and producing medical preparatives containing it
SK82399A3 (en) Heteroaryl sulfonamide compounds, process for their preparation, pharmaceutical compositions containing them and their use
JP4890268B2 (ja) ベンゾピラン誘導体、これの生産方法、およびこれの使用
KR100425953B1 (ko) 티오피란유도체
EP1572672B1 (en) Benzoxazocines and their use as monoamine-reuptake inhibitors
NO309477B1 (no) Nye heterocykliske aminometylforbindelser, fremgangsmåte ved fremstilling av dem og farmasöytiske sammensetninger som inneholder dem
BG108531A (bg) Нови х...'...роарилни производни, 'яхно'о пол"-аван... и използван...
HU224312B1 (hu) 2-Amino-indán-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
WO2001072741A2 (en) N-benzodioxanylmethyl-1-piperidyl-methylamine compounds for the treatment of central nervous system disorders
MXPA02005485A (es) Compuestos triciclicos y metodo de tratamiento del virus del herpes.
SK17602000A3 (sk) N-benzodioxanylmetyl-1-piperidyl-metamínové zlúčeniny majúce afinitu k 5-ht receptorom
MXPA99005997A (en) Sulfonamide compounds having 5-ht receptor activity
KR840001095B1 (ko) 2, 4-디아미노퀴나졸린 화합물의 제조 방법
CZ232799A3 (cs) Sulfonamidové sloučeniny s aktivitou receptorů 5-HT
DK150305B (da) Analogifremgangsmaade til fremstilling af tetrahydrothiopyrano (3,2-b)indol-derivater
RU1836345C (ru) Способ получени полициклических биоцидных соединений или их солей
KR100254665B1 (ko) 신경이완제 등으로서 유용한 n-치환된 3-아자비시클로(3.2.0)헵탄 유도체
CZ20004461A3 (cs) Terapeutické činidlo